Literature DB >> 15030458

Postmenopausal hormone therapy: the pros and cons.

L M Rivera-Woll1, S R Davis.   

Abstract

The use of postmenopausal hormone therapy (HT) has recently generated much debate following the results of various large randomised controlled trials. This has challenged physicians to reassess the use of HT in each individual woman within the realm of her symptomatology and risk profile for long-term illnesses. There are several areas of definite benefit or risk and many areas of uncertainty. The results of recent randomised controlled trials pertain to the specific HT regimens used and the characteristics of the study groups, such that the conclusions cannot be extrapolated to the use of HT in general.

Entities:  

Mesh:

Year:  2004        PMID: 15030458     DOI: 10.1111/j.1444-0903.2004.00555.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  2 in total

1.  [Skin aging].

Authors:  E Kohl; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

2.  Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.

Authors:  Ornella de Bari; Helen H Wang; Piero Portincasa; Chang-Nyol Paik; Min Liu; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2014-11-04       Impact factor: 4.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.